Innovation in the pharma industry (part 1): how well is pharma driving innovation?

pharmaphorum

In association with Cegedim Relationship Management

pharmaphorum spoke with a number of attendees of the Cegedim Relationship Management’s ‘2012 Life Science Forum’, on their views on how well pharma is currently driving innovation. Their responses can be seen in this video in the first of this four-part video series.

Traditionally, pharma has relied on blockbuster drugs to thrive. It’s been clearly established that in order to survive in the evolving health landscape pharma needs to act truly innovatively and move forward with a new way of thinking. But how well is pharma currently driving innovation?

Cegedim Relationship Management’s ‘2012 Life Science Forum’ was focused around how innovation will transform the life sciences industry. pharmaphorum attended the event and asked several attendees ‘how well is pharma currently driving innovation?’ Their responses can be viewed in the video below.

This is the first of a four-part video series looking at innovation within pharma. Future videos will address challenges to innovation, what pharma can do to drive innovation and what the future of innovation in pharma looks like.

Watch the short video review below to find out who we spoke with and what they shared.

Subscribe to pharmaphorum on YouTube to be the first to hear about new videos – youtube.com/pharmaphorum.

Other videos in this series on innovation in the pharma industry can be viewed at the following links:-

Part 2: what challenges are there to implementing innovation?

Part 3: what can help pharma to drive innovation?

Part 4: how do you see delivery of innovation changing for pharma in the future?

The full video can be viewed on YouTube here.

Cegedim Relationship Management

About Cegedim Relationship Management:

With a presence in more than 80 countries, Cegedim Relationship Management combines its global expertise with a deep understanding of local markets to help clients promote and market their products in the most efficient and cost-effective manner.

How well do you think pharma is currently driving innovation?